Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Reunite to Raise Hands against Diabetes
- Diabetes Conference 2019

Welcome message

It is a great pleasure and an honor to extend to you a warm invitation to attend the "3rd International Conference on Diabetes, Nutrition, Metabolism & Medicare", going to be held during July 25-26, 2019 in Amsterdam, Netherlands.


The theme of the 2019 Conference  ‘Reunite to Raise Hands against Diabetes’ will underpin the need for collaboration and cooperation of individuals from a wide range of professional backgrounds.


This will provide a wonderful forum for you to refresh your knowledge base and explore the innovations in Diabetes, NutritionMetabolismMedicare. The Congress will strive to offer plenty of networking opportunities, providing you with the opportunity to meet and interact with the leading scientists and researchers, friends and colleagues as well as sponsors and exhibitors. We hope you will join us for a symphony of outstanding science, and take a little extra time to enjoy the spectacular and unique beauty of this region.

Scientific Sessions

Session 1: Diabetes Nutrition & Metabolism

 

The digestion and metabolism of individuals with diabetes differs to the digestion of individuals without diabetes. In diabetes mellitus, the adequacy of insulin is diminished whereas in type 1 diabetes, body insulin levels will be low. Consequently, in type 1 diabetes patients requires insulin conveyance from different strategies. Insulin resistance is more regular in pre-diabetes. Metabolic disorder and diabetes mellitus hinders the body's capacity to process the glucose. Thus blood glucose levels end up plainly raised, abnormal weight gain is probable and the imperviousness to insulin winds up noticeably more noteworthy. Diabetes and cardiovascular malady can be anticipated by solid eating regimen and way of life style.

 

Diabetic Nutrition involves a few dietary intercession trials in individuals with pre-diabetes demonstrated that diabetes hazard was decreased by 40% when compared with the control gather took after amid 10 years. Among the people at high cardiovascular risk, the current PREDIMED trial demonstrates that parts of a Mediterranean eating routine expended over 5 years of follow-up period decreases the cardiovascular illness chance by 30%.

 

The sole distinction is the volume/effectiveness of the insulin produced in the body. There is a selected organic process through which insulin is produced inside the body of person. Insulin therapy is usually recommended for patients with diabetes mellitus and an initial A1c level greater than 9%. Insulin therapy is also started as augmentation, beginning at 0.3units/kg or as a replacement, beginning at 0.6 to 1.0units/ kg. Metformin should be continued if possible because it is proven that it will reduce all-cause mortality and cardiovascular risks in diabetic overweight patients.

 

                     Diabetes, Metabolic Disorders and control

                     Pre-diabetes

                     Role of dietary modification for diabetes

                     Role of trace elements in glucose homeostasis

                     Role of micronutrients in early childhood nutrition

                     Diabetic counselling and prevention

                     Proteins and diabetes

                     Effect of macro-nutrient on Type 2 diabetic patients

                     Adult-onset diabetes and nutrients requirement

                     Dietary approaches to diabetes

                     Glycaemic index

                     Supplements and vitamins

                     Metabolism process

                     Drug Metabolism & Insulin action

                     Metabolism related to various methods of drug administration.

                     Metabolism in type 1 diabetes

                     Metabolism in obesity-related diabetes mellitus

 

Related Societies and Associations: Union of Diabetics of Czech Republic, Czech Republic; American Association of Clinical Endocrinologists, USA, Barton Center for Diabetes Education, USA; Diabetes Australia, Australia; Diabetes Australia Victoria, Australia; Croatian Diabetes Association, Croatia; Dr. Mohan’s Diabetes Specialities Centre, Tamil Nadu; Diabetes.co.uk, UK; Diabetes Technology Society, Europe; Diabetes NSW & ACT, Australia; Diabetes Hands Foundation, California.

 

Diabetes Conferences | Diabetes Conference 2019 | Medical Conferences | Nutrition Conferences | Metabolism Conferences | Medicare Conferences | Amsterdam Conferences | Healthcare Conferences | Diabetes Meet 2019 | Diabetes Expo 2019 | Clinical Diabetes 2019 | Global Diabetes 2019 | Diabetes Europe 2019 | USA Conferences | Netherlands Conferences | Diabetes Asia-Pacific meetings

 

 

Session 2: Diabetes Health Care and Medicare

 

Diabetic Medicare covers the fasting blood glucose test, which is a diabetes screening method. Medicare covers two diabetes screening methods each year for beneficiaries who are at high risk for diabetes. Risk factors for diabetes include: high blood pressure, history of abnormal triglyceride and sterol levels, obesity, or a history of high glucose levels. If this disorder runs in a family, they may also need regular diabetes testing. Diabetic Medicare may include, Glucose control solution or Lancet devices or Lancets  or Therapeutic shoe as prescribed by your doctor. Diabetes Healthcare includes

 

According to the CMS (Centres for Medicare and Healthcare), 32nd of Medicare outlay is attributed exclusively for the diabetes population. Since its inception, Medicare has expanded over medical coverage of monitoring devices, academic efforts, screening tests and visits, preventive medical services for its diabetic enrolees. However, the hypoglycaemic agents and drugs were excluded from the reimbursement. In 2003, Congress passed the Medicare Modernization Act that has a drug profit to be administered either through medicare advantage drug plans or by private sponsored prescription medical plans for implementation in January 2006.

 

                     Medicare Advantages and Disadvantages

                     Diabetes Statistics

                     Diabetes Facts & Myths

                     Economic Costs

                     Pharmacoeconomic Factors

                     Cost effective analysis

                     Health care cost

                     Economic analysis

                     Diabetic medicare benefits

                     Medicare approved glucose meters, test strips

                     Medicare diabetic supplies

                     Diabetic medicare shoes

 

Related Societies and Associations: Union of Diabetics of Czech Republic, Czech Republic; American Association of Clinical Endocrinologists, USA, Barton Center for Diabetes Education, USA; Diabetes Australia, Australia; Diabetes Australia Victoria, Australia; Croatian Diabetes Association, Croatia; Dr. Mohan’s Diabetes Specialities Centre, Tamil Nadu; Diabetes.co.uk, UK; Diabetes Technology Society, Europe; Diabetes NSW & ACT, Australia; Diabetes Hands Foundation, California.

 

Diabetes Conferences | Diabetes Conference 2019 | Medical Conferences | Nutrition Conferences | Metabolism Conferences | Medicare Conferences | Amsterdam Conferences | Healthcare Conferences | Diabetes Meet 2019 | Diabetes Expo 2019 | Clinical Diabetes 2019 | Global Diabetes 2019 | Diabetes Europe 2019 | USA Conferences | Netherlands Conferences | Diabetes Asia-Pacific meetings

 

Session 3:  Diabetes Women health

 

Diabetes affects women and men in almost equal numbers however; it affects women differently than men. When compared with diabetic men, diabetic women have a higher risk for heart disease, lower survival rates and a poorer quality of life after heart attack, higher risk for blindness. Depression affects twice as many women as men, also raises the risk for diabetes in women. It safe for women with diabetes to get pregnant, If you have type 1 or type 2 diabetes, you can have a healthy pregnancy. If you have diabetes and you want to have a baby, then you need to plan ahead, before you get pregnant. According to statistics about 15 million women in the United States have diabetes, or about 1 in every 9 adult women and the study also indicates the death rate for women with diabetes didn’t improve.

 

The death rate was higher among women, but there has been a shift in sex distribution of diabetes showing higher death rates in men and also the difference in death rates between women who had diabetes and those who didn’t had diabetes is more than doubled. The studies emphasize how diabetes affects men and women differently. It’s difficult to diagnose some of the complications of diabetes in women. An overgrowth of the Candida fungus can cause vaginal yeast infections, oral yeast infections, and vaginal thrush. These vaginal infections are common in women. Oral yeast infections often cause by a white coating on the tongue and inside the mouth. A high level of glucose in the blood triggers the growth of fungi. Urinary Tract Infections (UTI) are common in women with diabetes mostly due to the immune system being compromised because of high glucose levels. Diabetic neuropathy condition may also affect sensation in the vaginal area and lower a woman’s sex drive. Polycystic ovary syndrome may also cause a type insulin resistance which results in elevated blood sugar levels that increases the risk of developing diabetes.

Gestational diabetes is specific to pregnant women and it is different from other types like type 1 and type 2 diabetes. Gestational diabetes occurs approximately in 9.2% of pregnancies. The hormones of pregnancy interfere with the way of insulin works which causes the body to make more insulin. But in some women, this is still not enough insulin, and they develop gestational diabetes. Gestational diabetes often develops later in pregnancy and mostly goes away after pregnancy in most of the women.

 

                     Diabetes Complication in Pregnancy

                     How does diabetes affect women differently than men?

                     Symptoms of diabetes in women

                     Problems getting pregnant

                     Problems during pregnancy, including possible health problems for you and your baby

                     Repeated urinary and vaginal infections

                     Is it safe for women with diabetes to get pregnant?

                     Gestational diabetes

                     Risk factors for diabetes in women

 

Related Societies and Associations: Union of Diabetics of Czech Republic, Czech Republic; American Association of Clinical Endocrinologists, USA, Barton Center for Diabetes Education, USA; Diabetes Australia, Australia; Diabetes Australia Victoria, Australia; Croatian Diabetes Association, Croatia; Dr. Mohan’s Diabetes Specialities Centre, Tamil Nadu; Diabetes.co.uk, UK; Diabetes Technology Society, Europe; Diabetes NSW & ACT, Australia; Diabetes Hands Foundation, California.

 

Diabetes Conferences | Diabetes Conference 2019 | Medical Conferences | Nutrition Conferences | Metabolism Conferences | Medicare Conferences | Amsterdam Conferences | Healthcare Conferences | Diabetes Meet 2019 | Diabetes Expo 2019 | Clinical Diabetes 2019 | Global Diabetes 2019 | Diabetes Europe 2019 | USA Conferences | Netherlands Conferences | Diabetes Asia-Pacific meetings

 

Session 4: Neonatal diabetes and Pediatric diabetes

 

Neonatal diabetes is caused by a mutation in a gene that affects insulin production. Neonatal diabetes is a monogenic form of diabetes that occurs in the first 6 months after the birth. This means that blood glucose levels in the body rises very high. The main feature of neonatal diabetes is being diagnosed with diabetes less than 6 months of age and is different from Type 1 diabetes as Type 1 diabetes doesn’t affect anyone under the age of 6 months. About 20 per cent of children with neonatal diabetes also have some developmental delay resulting muscle weakness, learning difficulties and epilepsy.

 

Babies born to a diabetic women with are often much bigger, a condition called "macrosomia”, because their mothers have high blood glucose levels, they get too much glucose through the placenta. And in this condition the baby's pancreas senses it and makes more insulin to use it up. That extra glucose gets converted into fat, and makes the baby fatty.

Permanent neonatal diabetes mellitus is a type of diabetes that first appears within the 6 months of baby birth and persists throughout the lifespan. This type of  diabetes is characterized by high blood glucose levels i.e. hyperglycaemic condition resulting from the shortage of the insulin hormone.

 

The combination of developmental delay, epilepsy, and neonatal diabetes combined called as DEND syndrome. And Intermediate DEND syndrome is a similar to DEND syndrome but with milder developmental delay and without epilepsy. In some cases with permanent neonatal diabetes have an underdeveloped pancreas.

 

Mostly Pediatric diabetes results in type 1 and is a lifetime dependence on exogenous insulin. In Pediatric diabetes it is mostly type 1 diabetes because child’s body makes little or no insulin due to an overactive immune system.

 

                     Neonatal & Paediatric Diabetes Symptoms

                     Risk factors of Neonatal & Paediatric diabetes

                     Neonatal & Paediatric diabetes prevention measures

                     Neonatal care for diabetics

                     Different stages of diabetes

                     Diabetes statistics in children

                     Neonatal Endocrinology

                     Pediatric Endocrinology

                     Adolescent Endocrinology

                     Diabetes Nutrition in Child

                     Psychological care for diabetic children

                     Maturity Onset Diabetes of the Young

 

 

Related Societies and Associations: Union of Diabetics of Czech Republic, Czech Republic; American Association of Clinical Endocrinologists, USA, Barton Center for Diabetes Education, USA; Diabetes Australia, Australia; Diabetes Australia Victoria, Australia; Croatian Diabetes Association, Croatia; Dr. Mohan’s Diabetes Specialities Centre, Tamil Nadu; Diabetes.co.uk, UK; Diabetes Technology Society, Europe; Diabetes NSW & ACT, Australia; Diabetes Hands Foundation, California.

 

Diabetes Conferences | Diabetes Conference 2019 | Medical Conferences | Nutrition Conferences | Metabolism Conferences | Medicare Conferences | Amsterdam Conferences | Healthcare Conferences | Diabetes Meet 2019 | Diabetes Expo 2019 | Clinical Diabetes 2019 | Global Diabetes 2019 | Diabetes Europe 2019 | USA Conferences | Netherlands Conferences | Diabetes Asia-Pacific meetings

 

Session 5: Diabetic Foot care

 

Diabetes can be dangerous to your feet; even a small cut in diabetic patients can produce serious consequences. Diabetes may cause the nerve damage that takes away the sense of your feet. Diabetes may also reduce the flow of blood to the feet, making it harder to resist infection or heal an injury. Serious foot problems could result in losing a toe, foot or leg.

To avoid foot issues in diabetes patients we need to Inspect your feet daily, Bathe feet in lukewarm, never use hot water, Be gentle when bathing your feet, Moisturize your feet but not between your toes, Cut nails carefully, Never treat corns or calluses yourself, Wear clean & dry socks, Consider socks made specifically for patients living with diabetes, Wear socks to bed, Shake out your shoes and feel the inside before wearing, Keep your feet warm and dry, Consider using an antiperspirant on the soles of your feet, Never walk on barefoot, Control of your diabetes, Do not smoke, Get periodic foot exams.

 

                     Preventive Foot Care in Diabetes

                     Caring for Your Feet

                     Risk factors for Diabetic Foot Ulcers

                     Diabetic Foot Ulcer Symptoms & Diagnosis

                     Diabetic Foot Ulcer Treatments & Care

                     Diabetic Neuropathy and its types

                     Diabetic Neuropathy Treatment

 

 

Related Societies and Associations: Union of Diabetics of Czech Republic, Czech Republic; American Association of Clinical Endocrinologists, USA, Barton Center for Diabetes Education, USA; Diabetes Australia, Australia; Diabetes Australia Victoria, Australia; Croatian Diabetes Association, Croatia; Dr. Mohan’s Diabetes Specialities Centre, Tamil Nadu; Diabetes.co.uk, UK; Diabetes Technology Society, Europe; Diabetes NSW & ACT, Australia; Diabetes Hands Foundation, California.

 

Diabetes Conferences | Diabetes Conference 2019 | Medical Conferences | Nutrition Conferences | Metabolism Conferences | Medicare Conferences | Amsterdam Conferences | Healthcare Conferences | Diabetes Meet 2019 | Diabetes Expo 2019 | Clinical Diabetes 2019 | Global Diabetes 2019 | Diabetes Europe 2019 | USA Conferences | Netherlands Conferences | Diabetes Asia-Pacific meetings

 

Session 6: Diabetes Obesity and Weight Loss

 

Body Mass Index has a strong relationship to insulin resistance and diabetes. In obese individuals, the amount of glycerol, hormones, non-esterified fatty acids, cytokines, pro-inflammatory markers, and other substances that are involved in the development of insulin resistance. The pathogenesis of diabetes is based on the fact that the ?-islet cells of the pancreas are impaired, causing a lack of control in blood glucose levels. The diabetes onset becomes more inevitable if the failure of ?-islet cells of the pancreas is accompanied by insulin resistance. Weight gain and body mass are central to the formation and rising incidence of diabetes.

Overweight and obesity may be defined as an excess accumulation of adipose tissue to an extent that impairs physio-psychosocial health and well-being of individuals. Obesity is considered as a health disaster in both developed and developing countries now a day due to different lifestyles. The prevalence is increasing significantly in many nations worldwide. This pandemic needs to be stopped if the social hazards, economic costs, morbidity, and mortality of the disease are considered.

 

Diabetes and obesity are chronic disorders that are on the peaks all over the world. Gaining weight in early life is associated with the development of diabetes mellitus. NEFA is a cornerstone in the impairment of ?-cell function and in the development of insulin resistance. In some cases not only increase in BMI we may also observe e sudden weight loss.

 

                     Obesity and type I diabetes

                     Obesity and type II diabetes

                     Obesity’s Role in the Development of Diabetes

                     Mechanisms of obesity-associated insulin resistance

                     Mechanisms of progressive ?-cell dysfunction in obese individuals

                     Genetic factors linking obesity and diabetes

                     Childhood Obesity

                     Bariatric Surgery

                     Overweight-major cause

                     Insulin resistance and inflammatory response

                     Increased 24 hour Expenditure during type 2 Diabetes

                     Disruption in fat metabolism

                     Measurement of BMR and sleeping energy expenditure

                     Development of effective treatment options

                     Integrated physiology/obesity

 

Related Societies and Associations: Union of Diabetics of Czech Republic, Czech Republic; American Association of Clinical Endocrinologists, USA, Barton Center for Diabetes Education, USA; Diabetes Australia, Australia; Diabetes Australia Victoria, Australia; Croatian Diabetes Association, Croatia; Dr. Mohan’s Diabetes Specialities Centre, Tamil Nadu; Diabetes.co.uk, UK; Diabetes Technology Society, Europe; Diabetes NSW & ACT, Australia; Diabetes Hands Foundation, California.

 

Diabetes Conferences | Diabetes Conference 2019 | Medical Conferences | Nutrition Conferences | Metabolism Conferences | Medicare Conferences | Amsterdam Conferences | Healthcare Conferences | Diabetes Meet 2019 | Diabetes Expo 2019 | Clinical Diabetes 2019 | Global Diabetes 2019 | Diabetes Europe 2019 | USA Conferences | Netherlands Conferences | Diabetes Asia-Pacific meetings

 

Session 7: Diabetes and Other Complications

 

Diabetes is a group of diseases that results in too much glucose levels in the blood.  Consistently high blood glucose levels lead to serious diseases affecting the heart, nerves, eyes, kidneys, mouth and also nerves resulting Diabetic Neuropathy. In addition, people with diabetes are also at a higher risk of developing several infections like oral infections and all. Almost in all high-income countries, diabetes is one of a leading cause of cardiovascular diseases, blindness, kidney failures, and lower limb amputation. Studies shows that generation of diabetes people determine the health risk factors for developing heart disease and showed that multiple health factors including diabetes could increase the possibility of developing cardiac diseases.

 

Diabetic eye illness includes a gathering of different eye conditions that influence diabetic individuals. These conditions incorporate (DME)Diabetic Macular Edema, Diabetic Retinopathy and Glaucoma. All types of diabetic eye illness can possibly cause extreme vision dysfunction and visual impairment. Diabetic retinopathy is the most well-known reason for vision misfortune among diabetic individuals and the main source of visual deficiency among grown-ups and working-age.

 

Diabetes people who have sporadic blood glucose levels have a higher danger of gum infection and tooth issues than individuals without diabetes. In Diabetes oral fungal infections, tooth decay and periodontal diseases are majorly observed.

Diabetic nephropathy is damage to your kidneys caused as a diabetes complication. In severe cases, it can lead to chronic kidney failure. Diabetes insipidus (DI) may be defined as the passage of large volumes of dilute form of urine. And in this case Polyuria and Nocturia are common symptoms and hence people with diabetes are at increased risk of renal atherosclerosis, papillary necrosis, urinary tract infections and glomerular lesions and glomerulo sclerosis.

 

Dermatologic issues are also a basic issue in diabetes, with roughly 30% of patients encountering some cutaneous association over the span of their sickness. Pharmacologic administration of diabetes can likewise bring on some skin changes, for instance lipohypertrophy & lipoatrophy at the site of infusion of insulin, and oral anti diabetic operators may cause numerous skin responses as antagonistic impacts.

 

                     Diabetes - Oral Health

                     Diabetes - Dermatology

                     Diabetic Nephropathy

                     Diabetic Retinopathy

                     Diabetic Neuropathy

                     Diabetic Nephropathy

                     Diabetes and Cardiovascular Diseases

                     Diabetes Complication in Type 1 & Type 2

                     Diabetes Complication: Macro vascular and micro vascular

                     Future of Diabetes Complication

 

Related Societies and Associations: Union of Diabetics of Czech Republic, Czech Republic; American Association of Clinical Endocrinologists, USA, Barton Center for Diabetes Education, USA; Diabetes Australia, Australia; Diabetes Australia Victoria, Australia; Croatian Diabetes Association, Croatia; Dr. Mohan’s Diabetes Specialities Centre, Tamil Nadu; Diabetes.co.uk, UK; Diabetes Technology Society, Europe; Diabetes NSW & ACT, Australia; Diabetes Hands Foundation, California.

 

Diabetes Conferences | Diabetes Conference 2019 | Medical Conferences | Nutrition Conferences | Metabolism Conferences | Medicare Conferences | Amsterdam Conferences | Healthcare Conferences | Diabetes Meet 2019 | Diabetes Expo 2019 | Clinical Diabetes 2019 | Global Diabetes 2019 | Diabetes Europe 2019 | USA Conferences | Netherlands Conferences | Diabetes Asia-Pacific meetings

 

Session 8:  Diabetes distress

 

Diabetes distress refers to an emotional state of diabetic individuals that experience feelings such as stress, frustrated, guilty, sad, or worried, or denial that arise from living with diabetes and it becomes the burden of self-management. Diabetes distress has also been linked to worse health outcomes of an individual. The presence of major depressive disorder in diabetic people may be up to three times more common than in the general population. Among Diabetic individuals, there are some major sources of Diabetes Distress and they are powerlessness, negative social perceptions, Physician Distress, Friend/Family Distress, Hypoglycaemia Distress, and Eating Distress. Early recognition and treatment of diabetes distress and depression are essential to achieve optimal goals in the management of depression and overall quality of life.

 

Symptoms of Diabetes distress may include feeling overwhelmed by the demands of  living with diabetes, fail in following the prescribed diabetes routine, feeling unsupported by family and friends; feeling frustrated, angry and scared, depressed about living with diabetes and feeling that long term diabetic complications are inevitable.

 

In some patients, high levels of diabetes distress can lead to reduced self-management and medication adherence and in some others, poor diabetes control can lead to distress.  If screening tools suggest that a patient has depression, it’s necessary to approach a Psychologist.

 

                     Overview: Diabetes Distress and Depression

                     Strategies for Dealing With Diabetes Distress

                     Diabetes Distress Scale

                     Symptoms of Diabetes Distress

                     Screening for Diabetes Distress

                     Treatment of  Diabetes Distress

                     Emotional burden of Diabetes Distress

                     Doctor–patient relationship specially in Diabetes Distress

                     Diabetes regimen

                     Interpersonal Diabetes Distress

                     Management of Diabetes Distress

 

 

Related Societies and Associations: Union of Diabetics of Czech Republic, Czech Republic; American Association of Clinical Endocrinologists, USA, Barton Center for Diabetes Education, USA; Diabetes Australia, Australia; Diabetes Australia Victoria, Australia; Croatian Diabetes Association, Croatia; Dr. Mohan’s Diabetes Specialities Centre, Tamil Nadu; Diabetes.co.uk, UK; Diabetes Technology Society, Europe; Diabetes NSW & ACT, Australia; Diabetes Hands Foundation, California.

 

Diabetes Conferences | Diabetes Conference 2019 | Medical Conferences | Nutrition Conferences | Metabolism Conferences | Medicare Conferences | Amsterdam Conferences | Healthcare Conferences | Diabetes Meet 2019 | Diabetes Expo 2019 | Clinical Diabetes 2019 | Global Diabetes 2019 | Diabetes Europe 2019 | USA Conferences | Netherlands Conferences | Diabetes Asia-Pacific meetings

 

Session 9:  Diabetes Risk factors

 

Diabetes can be hereditary; one of the most important reasons of widespread of this disease can be the transforming life style of the today’s world population. As we can see in recent days people used to prefer bike, car or any vehicle to cover very small distances which causes physical inactivity and that finally leads to obesity or overweight, which is the main cause of Diabetes and other chronic diseases. In Ancient times people used to do meditation and yoga

 to relax their body and mind whereas in current time people stopped all such physical activities which is leading to emotional and mental stress finally can be the cause of diabetes like chronic diseases.

 

Common risk factors or symptoms of Diabetes

 include increased over weight, cholesterol and blood fat levels, blood pressure.

 

There are 3 types of Diabetes: Type 1, Type 2 and Gestational Diabetes in all the 3 body can’t make or use insulin. Current scenario of Diabetes is critical as the several people suffering from Diabetes have raised from 108 million in 1980 to 422 million in 2014. Diabetic prevalence has been raising rapidly in middle and low income countries day to day; it is also becoming major cause of many health issues kidney failures, heart attacks, stroke blindness and lower limb amputation. Almost half of deaths attributable to high blood glucose levels occur before the age of 70 years.

 

There are many risk factors related to different types of Diabetes can be caused because of family history, dietary factors, geography, disease of the pancreas, and infection or illness whereas Type 2 Diabetes can be occurred due to Obesity is being overweight, insulin resistance, impaired glucose tolerance, ethnic background, high blood pressure, Low levels of cholesterol and high levels of triglycerides, sedentary lifestyle, polycystic ovary syndrome and age.

 

                     Impaired Glucose tolerance

                     Polycystic ovary syndrome

                     Diseases of the pancreas

                     Infection or illness

                     Laws and Regulations

                     Practical considerations

                     Insulin Resistance

                     High blood pressure and obesity

                     Ethnic & Family Background

                     Overweight or Obese

                     Age factor

                     Physical Inactivity

                     Mental and emotional stress

                     Allied disease like high blood pressure

 

 

Related Societies and Associations: Union of Diabetics of Czech Republic, Czech Republic; American Association of Clinical Endocrinologists, USA, Barton Center for Diabetes Education, USA; Diabetes Australia, Australia; Diabetes Australia Victoria, Australia; Croatian Diabetes Association, Croatia; Dr. Mohan’s Diabetes Specialities Centre, Tamil Nadu; Diabetes.co.uk, UK; Diabetes Technology Society, Europe; Diabetes NSW & ACT, Australia; Diabetes Hands Foundation, California.

 

Diabetes Conferences | Diabetes Conference 2019 | Medical Conferences | Nutrition Conferences | Metabolism Conferences | Medicare Conferences | Amsterdam Conferences | Healthcare Conferences | Diabetes Meet 2019 | Diabetes Expo 2019 | Clinical Diabetes 2019 | Global Diabetes 2019 | Diabetes Europe 2019 | USA Conferences | Netherlands Conferences | Diabetes Asia-Pacific meetings

 

Session 10: Alternative and traditional Therapies

 

Treatments for diabetes include several methods additionally to standard treatments such as modern drugs and injections there are certain claims made regarding various alternative and complementary treatments for diabetes which includes health treatments that aren't a part of standard Western practice. The class encompasses a wide range of disciplines that includes everything from diet and exercise to mental acquisition and lifestyle changes. Most of the plant foods are rich in fibres that are helpful to manage blood glucose levels normally. Buckwheat, Broccoli, Brewer's yeast and other related greens, Peas, Okra, Fenugreek seeds, Sage are some of the food that contain anti-diabetic agents.

 

Alternative to these artificial agents, plants provided a potential supply of hypoglycaemic drugs and are widely utilized in many ancient systems of medicine

 to prevent diabetes. Several medicinal plants have been investigated for their beneficial effects for numerous types of diseases. Other alternative therapies such as acupuncture, dietary supplements and yoga therapies are likely to have the fewer side effects of typical approaches for diabetes. About one-third of people with diabetes use some methods of Complementary and Alternative Medicine therapies (CAM therapies). “Integrative medicine” also used in the diabetes treatment is a combination of ancient medicine and Complementary and Alternative Medicine therapies. These Complementary and Alternative Medicine therapies are recognized to ease the suffering of many of the individuals with chronic diseases, along with diabetes. However, before subscribing to any of the alternative therapies, it is necessary to consult your regular health care team and your doctor avoid further complications.

 

                     Acupuncture

                     Hydrotherapy

                     Herbs and supplements

                     Mind body medicine

                     Yoga therapy

                     Chinese Traditional Medicine for Diabetes

 

Related Societies and Associations: Union of Diabetics of Czech Republic, Czech Republic; American Association of Clinical Endocrinologists, USA, Barton Center for Diabetes Education, USA; Diabetes Australia, Australia; Diabetes Australia Victoria, Australia; Croatian Diabetes Association, Croatia; Dr. Mohan’s Diabetes Specialities Centre, Tamil Nadu; Diabetes.co.uk, UK; Diabetes Technology Society, Europe; Diabetes NSW & ACT, Australia; Diabetes Hands Foundation, California.

 

Diabetes Conferences | Diabetes Conference 2019 | Medical Conferences | Nutrition Conferences | Metabolism Conferences | Medicare Conferences | Amsterdam Conferences | Healthcare Conferences | Diabetes Meet 2019 | Diabetes Expo 2019 | Clinical Diabetes 2019 | Global Diabetes 2019 | Diabetes Europe 2019 | USA Conferences | Netherlands Conferences | Diabetes Asia-Pacific meetings


Session 11: Advanced Therapies & diagnostic methods

 

There are much advancement in Diabetic Treatment and Diagnosis but when one is dealing with the day to day management of Diabetes, it may seem to be slow. There are many tools that  help you to maintain Diabetes like what you eat, how much you exercise and how much you feel each day, what your blood sugar levels are, some of these include smartphones, tablets to note your blood sugar or meal and snacks, devices that test your sugar levels for every minute, new inventions like Smart Pumps. Indeed, it may be argued that the key advances in Diabetic care created inside the half-moon of a century that has come back from technology instead of biology. At a similar time, not all recent technologies succeed have for instance we can take Glucowatch. Patients and their attention suppliers can before long see a series of additional advanced medical technologies utilized in hospital, novel therapies and new technologies in diabetes treatment whose basis is tied to the notion of raising the lives of these with the diabetes.

 

The concept of new innovations and emerging therapies like reverse diabetes therapy for the treatment of diabetes has expanded in recent years. There is a lot of latest research on diabetes happening and the latest includes some very rare forms of diabetes which are caused due to single gene mutations which are called as "monogenic" forms of diabetes. And new research is opening the door to specific treatments for these diabetes patients. With the advanced diabetes treatment various devices like insulin pumps are used for the administration of insulin (insulin pen), bio-markers, rapid HbA1c monitoring, Nano medicine, artificial pancreas etc. are formed for the treatment. Number of innovations and treatments are increasing with the increase in research work by Research and development departments in various sectors and endocrinology is getting treatment with these devices. Continuous Glucose Monitoring (CGM) is a relatively a new technology which has the potential to assist people living with type 1 Diabetes or type 2 Diabetes and is treated with insulin to achieve the goal of optimum control of blood glucose level. This will remove the diabetes cholesterol from the blood and reduce the risks. Surely, Diabetes Conference 2019 will be successful in bringing forward the results.

 

                     Current Advancements in Management of diabetes

                     New therapeutic mechanisms for Diabetes

                     Computational approach to chemical etiologist of Diabetes

                     Glucose sensors (invasive and non-invasive)

                     Insulin Pens and novel Insulin delivery techniques

                     Bariatric surgery versus conventional therapy

                     New drug treatments and devices for diabetes: current research

                     Biomarker as Diagnostic tool for Diabetes

                     Insulin pumps and insulin infusion systems

                     Artificial pancreas

                     Challenges in the adoption of technology into Diabetes care

                     Advanced medical technologies used in hospitals

                     Bio- stator: closed loop system

                     Advances in Diabetes and insulin therapy

                     Recent Advances in Treatment of Diabetes mellitus

                     Personalized medicine

                     New insulin delivery systems: Inhaled, transdermal, and implanted devices

 

Related Societies and Associations: Union of Diabetics of Czech Republic, Czech Republic; American Association of Clinical Endocrinologists, USA, Barton Center for Diabetes Education, USA; Diabetes Australia, Australia; Diabetes Australia Victoria, Australia; Croatian Diabetes Association, Croatia; Dr. Mohan’s Diabetes Specialities Centre, Tamil Nadu; Diabetes.co.uk, UK; Diabetes Technology Society, Europe; Diabetes NSW & ACT, Australia; Diabetes Hands Foundation, California.

 

Diabetes Conferences | Diabetes Conference 2019 | Medical Conferences | Nutrition Conferences | Metabolism Conferences | Medicare Conferences | Amsterdam Conferences | Healthcare Conferences | Diabetes Meet 2019 | Diabetes Expo 2019 | Clinical Diabetes 2019 | Global Diabetes 2019 | Diabetes Europe 2019 | USA Conferences | Netherlands Conferences | Diabetes Asia-Pacific meetings

Abstract Submission & Registration

Abstract Submission Details

We warmly invite you to submit your abstract and attend the 3rd International Conference on Diabetes, Nutrition, Metabolism & Medicare. Submit your abstract online at Speaker abstract.

Come Let’s Bring a Transformation in the Scientific Society!!

The Young Researchers Forum offers young researchers the possibility to meet and discuss research topics and methodologies, share and develop ideas, learn from each other and gain knowledge from senior researchers. 

Young Researcher Sessions are organized at the Diabetes Conference 2019, to provide a unique platform for Young Researchers / Investigators for presenting latest research projects with an in-depth analysis. Allied Academies cordially invites Young Researchers from Universities/Institutes/Industries to present a short oral presentation during the forum. These oral presentations should be of 10 minutes duration in related scientific track followed by 5 minutes question hour. Therefore, presenters are encouraged to give comprehensive and dynamic talks. Applications will be selected based on past research productivity and future promise.

The abstract/s can be submitted online under Submit Abstract in Homepage or through e-mail at diabetesconference@alliedconference.com

Register Here: http://diabetesconference.alliedacademies.com/registration

Market Analysis

Today’s Market Study of Diabetes in USA Europe | Middle East Asia Pacific

Europe: The number of people living with diabetes in Europe is expected to increase from 52 million in 2014 to 68.9 million by 2035, according to the International Diabetes Federation (IDF). Across Europe, around 1 in 11 adults is affected and this number is set to rise as the population ages.

USADiabetes Mellitus has been growing at an exponential rate and World Health Organization (WHO) estimates that the diabetic population is likely to reach 366 million in 2030. The United States is expected to have an increase of 102 percent in the diabetic epidemic in 2030 when compared to 2000.

Middle East: The rate of diabetes in parts of the Arabian Peninsula is over twice the global average rate, and much higher than some other areas of the Middle East and North Africa (MENA). And cases of type-2 diabetes outnumber cases of type-1 diabetes by a ratio of 10:1.

Asia Pacific: The Asia-Pacific Diabetes Care Devices Market has been estimated at USD 2.461 Billion in 2015 and is projected to reach USD 3.518 billion by 2020, at a CAGR of 7.41% during the forecast period from 2015 to 2020.

Why Philadelphia???

Philadelphia, Pennsylvania’s largest city, is notable for its rich history, on display at the Liberty Bell, Independence Hall (where the Declaration of Independence and Constitution were signed) and other American Revolutionary sites. Also iconic are the steps of the Philadelphia Museum of Art, immortalized by Sylvester Stallone’s triumphant run in the film "Rocky." And many more tourists attractions.


Market Value on Diabetic Research:
The impact of diabetes on the individual quality of life and the general economy in Italy is substantial. Healthcare costs for patients with diabetes in Italy are estimated at approximately €5.5 billion annually, representing more than 6% of total national healthcare spending. The Cost of Diabetes in Europe—Type 2 Study(CODE-2), which measured the total healthcare costs for patients with type 2 diabetes in 8 European countries (Italy, Belgium, France, Germany, Netherlands, Spain, Sweden, and UK), found the total yearly (1998) costs for people with type 2 diabetes in Italy alone to be almost €5.2 billion, a per-patient expenditure of at least €2900. Among patients with type 2 diabetes in Italy examined by the CODE-2 study, 17.8% were hospitalized during the 6-month study, with an average hospital stay of 13 days. The cost of hospitalizations accounted for the greatest portion of total costs for all countries in the study, at 55%, leading non-anti diabetic drugs (21%), outpatient care (18%) and anti-diabetic drugs (7%).Among non-anti diabetic drugs, the majority were cardiovascular and lipid-lowering (42%).Annual per-patient costs vary widely with primary treatment type, with the highest per-patient costs accrued by those treated with diet and exercise alone.


Future Prospects:
Scientists are starting to get energized again that a cure or close cure treatment could come as right on time as inside the following decade or two. A diabetes immunization diabetes antibody is reliably being explored to give a genuine organic cure to sort 1 diabetes. The point is for an 
immunization to be made that prevents the invulnerable framework from assaulting the body's insulin-delivering beta cells. Another cure prospect picking up force is islet cell embodiment, with foundational microorganisms used to make insulin-creating cells that can work without invulnerable framework impedance. Research into a diabetes antibody is being made on a few fronts, with Selecta Bioscience, a clinical bioscience organization, building up a Synthetic Vaccine Particle (SVP) as an immunotherapy for sort 1 diabetes. The immunization is required to reinvent the invulnerable framework to forestall fiery reactions to insulin cells, with Selecta at present trailing SVP on mice graciousness of financing from JRDF, a main worldwide association subsidizing sort 1 diabetes investigate. Somewhere else, the Faust man Lab at Massachusetts General Hospital is at present driving a human clinical trial program to test the effectiveness of their Bacillus-Chalmette-Guerin (BCG) antibody. Positive outcomes have just been accounted for from their Phase I think about. A joint inflammation sedate, abatacept, has likewise indicated it can defer sort 1 diabetes movement a year after treatment has been suspended, with ponders again supported as a major aspect of JRDF's Restoration program.

Conclusion:

Over a time of research plainly recommends that insulin creating cells might be gotten from immature microorganisms. However, there is a requirement for promote the improvement of strategies for separation and choice of totally utilitarian cells. The recovery of cells is conceivable by controlling the direction of different variables. Investigation of these cell control pathways would be consistent steps towards the therapeutic endeavours in diabetes treatment. Regardless of the accomplishments and advance with the undifferentiated cells, the key issues like wellbeing concerns, teratoma arrangement, transplantation issues and immune system reaction, and moral situations of ESCs confine their further investigation in clinical trials. Also, the issues related with the scale-up generation, hamper the investigation of grown-up undifferentiated cells and iPSCs to be utilized as a decision of helpful assets. The logical exertion of a previous decade empowered us to deliver insulin discharging cells and the future years may concoct the answers for utilize foundational microorganisms as a helpful specialist to cure diabetes.

Importance & Scope:

The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030. The prevalence of diabetes is higher in men than women, but there are more women with diabetes than men. The urban population in developing countries is projected to double between 2000 and 2030. The most important demographic change to diabetes prevalence across the world appears to be the increase in the proportion of people >65 years of age. These findings indicate that the “diabetes epidemic” will continue even if levels of obesity remain constant. Given the increasing prevalence of obesity, it is likely that these figures provide an underestimate of future diabetes prevalence.

The number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. The global prevalence of diabetes* among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014. In 2012, an estimated 1.5 million deaths were directly caused by diabetes and another 2.2 million deaths were attributable to high blood glucose. Almost half of all deaths attributable to high blood glucose occur before the age of 70 years1. WHO projects that diabetes will be the 7th leading cause of death in 2030.

Diabetes Conference 2018 will feature the latest developments in research, diagnosis and prevention and management of diabetes, new insulin analogues and new technologies and devices for diabetic prevention, and for treating obesity and many more. Not only will this innovative conference enhance your practical and theoretical knowledge, it will provide you with the unique opportunity to network with a wide range of professionals in the field of diabetes technologies and treatments.

Target Audience:

International Conference on DiabetesNutritionMetabolism & Medicare includes the renowned scientists, geneticist, microbiologists, doctors, professors, public health planners, physicians, dietitians, pharmacists, students under the research of diabetes, industrial delegates and those using bioinformatics tools for studying under the single roof. The following are the data of audience:

·         Scientists      60%

·         Academia    30%

·         Others          10%

Diabetes Associations:
Different association in the world plays a vital role and their mission is to prevent and cure diabetes and to improve the lives of all people affected by 
disease. There are many associations playing a role in prevention worldwide as well as in countries.

Major Diabetes Associations around the Globe:

·         Diabetes Australia

·         Austrian Diabetes Association

·         Flemish Diabetes Association

·         (Association of Juvenile Diabetes (Brazil)

·         Canadian Diabetes Association

·         Juvenile Diabetes Foundation of Chile

·         Diabetological Colombian Federation

·         Croatian Diabetes Association

·         Union of Diabetics of Czech Republic

·         Estonian Diabetes Association.

 

Major association in USA:

·         American Association of Clinical Endocrinologists

·         American Diabetes Association

·         Centers for Disease Control: Division of Diabetes Translation

·         Diabetes Advocacy Alliance

·         Diabetes Hands Foundation

·         Juvenile Diabetes Foundation International

·         National Kidney Foundation

·         National Institute of Diabetes and Digestive and Kidney Diseases

·         International Diabetes Federation

·         Diabetes Association of Atlanta

Universities:

·         Harvard University

·         University of Oxford

·         University of Cambridge

·         Johns Hopkins University

·         Stanford University

·         Yale University

·         University of California, Los Angeles (UCLA)

·         Imperial College London

·         University of Melbourne

·         Karolinska Institute

Diabetes drugs:

There are a number of different types of diabetes drugs - with some having similar ways of acting. The 50+ diabetes drugs available in the world in the form of tablets or injection suspension and placed into different drug’s classes.

Below is the list of different classes of drugs used to treat diabetes:

·         Insulin

·         Biguanides / Metformin

·         Sulphonylureas

·         Meglitinides / Prandial glucose regulator / Glinides

·         Alpha-glucosidase inhibitors

·         Thiazolidinedione / Glitazones

·         DPP-4 inhibitors / Gliptins

·         Incretin mimetics / GLP-1 analogues

·         Amylin analogues

Diabetes drugs selling companies:

Diabetes is an epidemic in United States that is costing lives and money.  The top 10 best-selling diabetes drugs in the USA are

·         Lantus

·         Januvia

·         NovoLog/NovoRapid

·         Humalog

·         Victoza

·         Levemir

·         Human insulin and devices

·         Janumet

·         NovoMix 30

·         Humulin

 

Reference:

http://www.diabetes.co.uk/Diabetes-Cure.html

http://www.bbc.co.uk/science/0/21478094

http://www.planetware.com/tourist-attractions-/toronto-cdn-on-ont.htm

https://www.medical.theconferencewebsite.com/conferences/endocrinology-and-diabetes

http://www.diabetesincontrol.com/resources/case-studies/

https://en.wikipedia.org/wiki/Type_1_Diabetes_Association

http://www.webmd.com/diabetes/gestational-diabetes-guide/gestational_diabetes

http://www.emed.ie/Dermatology/Dermatology_Diabetes.php

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299750/

http://www.diabetes.co.uk/features/diabetes-and-oral-health.html

http://www.diabetes.org/living-with-diabetes/treatment-and-care/transplantation/pancreas-transplantation.html?referrer=https://www.google.co.in/

http://www.healthline.com/health/diabetes-foot-care

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355908/

 

Organizing Committee
OCM Member
Gerald C. Hsu
EclaireMD Foundation
Indiana, USA
OCM Member
Jaleel Kareem Ahmed
University of Babylon
Baghdad, Iraq
OCM Member
Dr. Ian Martins
Fellow of International Agency for Standards and Ratings (IASR)
Centre of Excellence for Alzheimer's Disease Research and Care Sarich Neuroscience Research Institute
Melbourne, Australia

To Collaborate Scientific Professionals around the World

Conference Date July 25-26, 2019
Speaker Oppurtunity Day 1 Day 2
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Sponsorship Opportunities Click here for Sponsorship Opportunities
Venue
&
Hospitality

Welcome to the official homepage of Diabetes Conference 2019 which will be held in the beautiful city of Amsterdam widely known for the cultural, financial  and commercial center of Netherlands.





Join The Discussion

Related Conferences

Contact Desk

Drop us an email for Program enquiry

Karleen Gloria

karleen.gloria@alliedscholars.com

+44 800 086 8979

Sponsors | Exhibiting | Advertising

diabetesconference@alliedconference.com

+1 800-858-2189

Special Issues
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
Media Partners
Collaborations

Allied Academies Global Conference Directory

Mail us at

Drop us an email for Program enquiry
karleen.gloria@alliedscholars.com
Sponsors | Exhibiting | Advertising
diabetesconference@alliedconference.com
USA/Canada
diabetesconference@alliedmeeting.org
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Responsibility

Delegates are personally responsible for their belongings at the venue. The Organizers will not be held responsible for any stolen or missing items belonging to Delegates, Speakers or Attendees; due to any reason whatsoever.

Insurance

Registration fees do not include insurance of any kind.

Transportation

Please note that any (or) all transportation and parking is the responsibility of the registrant.

Press/Media

Press permission must be obtained from Allied Academies Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. Allied Academies Pte. Ltd. is an objective third-party nonprofit organization. This conference is not associated with any commercial meeting company.

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference. Once your registration is complete, please contact diabetesconference.aa@gmail.com or 
diabetescare2018@gmail.com to request a personalized letter of invitation.

Regarding refunds, all bank charges will be for the registrant's account.

This cancellation policy was last updated on April 04, 2015.

Cancellation, Postponement, and Transfer of Registration

All cancellations or modifications of registration must be made in writing to finance@alliedacademies.com  

Cancellation Policy

If Allied Academies cancels this event for any reason, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies event which must occur within one year from the date of cancellation.

Postponement

If Allied Academies postpones an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies event which must occur within one year from the date of postponement.

Transfer of registration

All fully paid registrations are transferable to other persons from the same organization if registered person is unable to attend the event. Transfers must be made by the registered person in writing to finance@alliedacademies.com. Details must be included the full name of replacement person, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied Academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if it is intimated within 14 days of respective conference.

The transferred registrations will not be eligible for Refund.

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied Academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Allied Academies, including the inability to obtain a visa.

Refund Policy:

If the registrant is unable to attend and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-

  • Before 60 days of the conference: Eligible for Full Refund less $100 Service Fee
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.

Accommodation Cancellation Policy:

Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation. Allied Academies will advise the cancellation policy of your accommodation provider, prior to canceling or amending your booking, to ensure you are fully aware of any non-refundable deposits.

 

Highlights from last year's Convention

Authorization Policy

Copyright © 2018-2019 Allied Academies, All Rights Reserved.